Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y.-B. Park

Gastrointestinal Safety and Tolerability of Long-Term GCSB-5 of Dried Extracts of Six Herbs in Patients With Osteoarthritis: A 24 Weeks, Multi-Centers, Single Arm Phase IV Study

Osteoarthritis and Cartilage

Sports Medicine

Rheumatology

Orthopedics

Biomedical Engineering

2015

English

Prosthetic Reconstruction for Tumours of the Distal Tibia and Fibula

The Journal of Bone and Joint Surgery. British volume

1999

English

Related publications

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Alimentary Pharmacology and Therapeutics

English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics

Pharmacology

2016

English

Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study

Arthritis and Rheumatology

English

A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of CXD101 in Patients With Advanced Cancer

English

Short-Term Efficacy (At 12 Weeks) and Long-Term Safety (Up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Circulation Journal

Medicine

Cardiovascular Medicine

Cardiology

2020

English

Tolerability and Safety of the Intravenous Immunoglobulin Octagam® 10% in Patients With Immune Thrombocytopenia: A Post-Authorisation Safety Analysis of Two Non-Interventional Phase IV Trials

Hematology

2017

English

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Journal of Thoracic Oncology

English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System

English

Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors: A Phase I Study

Journal of Translational Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y.-B. Park

Gastrointestinal Safety and Tolerability of Long-Term GCSB-5 of Dried Extracts of Six Herbs in Patients With Osteoarthritis: A 24 Weeks, Multi-Centers, Single Arm Phase IV Study

Prosthetic Reconstruction for Tumours of the Distal Tibia and Fibula

Related publications

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study

A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of CXD101 in Patients With Advanced Cancer

Short-Term Efficacy (At 12 Weeks) and Long-Term Safety (Up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Tolerability and Safety of the Intravenous Immunoglobulin Octagam® 10% in Patients With Immune Thrombocytopenia: A Post-Authorisation Safety Analysis of Two Non-Interventional Phase IV Trials

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors: A Phase I Study